Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 545481 - 545500 out of 553697 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EL05) pirtobrutinib (adm: O) | JAYPIRCA 50MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell | EliLilly&Company |
| USA | (L01EL05) pirtobrutinib (adm: O) | JAYPIRCA 50MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell | EliLilly&Company |
| USA | (L01EM01) idelalisib (adm: O) | ZYDELIG 100MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Leukemia, Lymphocytic, Chronic, B-Cell | GileadSciences,Inc. |
| USA | (L01EM01) idelalisib (adm: O) | ZYDELIG 100MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Leukemia, Lymphocytic, Chronic, B-Cell | GileadSciences,Inc. |
| USA | (L01EM01) idelalisib (adm: O) | ZYDELIG 150MGTAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Leukemia, Lymphocytic, Chronic, B-Cell | GileadSciences,Inc. |
| USA | (L01EM01) idelalisib (adm: O) | ZYDELIG 150MGTAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Leukemia, Lymphocytic, Chronic, B-Cell | GileadSciences,Inc. |
| USA | (L01EM03) alpelisib (adm: O) | VIJOICE 50MG ORAL GRANULES | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | VIJOICE 50MG ORAL GRANULES | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | VIJOICE 125MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | VIJOICE 125MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | VIJOICE 50MG + 200MG TAB | 2X28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | VIJOICE 50MG + 200MG TAB | 2X28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | VIJOICE 50MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | VIJOICE 50MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | PIQRAY 150MGX28 (300MG) TAB,ORAL PKT | 2X28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | PIQRAY 150MGX28 (300MG) TAB,ORAL PKT | 2X28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | PIQRAY 200MGX28 (200MG) PKT | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | PIQRAY 200MGX28 (200MG) PKT | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | PIQRAY 200MGX14/50MGX14 (250MG) TAB,ORAL PKT | 2X28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | PIQRAY 200MGX14/50MGX14 (250MG) TAB,ORAL PKT | 2X28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsCorporation |
Pages
